People · Operator
Named in public records as an officer, director or promoter · active 2018–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CytoSite BioPharma Inc. | — | Biotechnology | Series A | $7.1M | $92.2M | 2018 |
Ellen Cordo at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ellen Cordo on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Smith | 1 | 11 |
| Robert Gailus | 1 | 4 |
| James Jenson | 1 | 3 |
| Stephen Sands | 1 | 2 |
| Mark Mintun | 1 | 1 |
| Michel Chu | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.